Seeking Alpha

Goldman Sachs upgrades Accretive Health (AH) to Buy from Neutral with a price target of $31....

Goldman Sachs upgrades Accretive Health (AH) to Buy from Neutral with a price target of $31. Analysts with the firm think investors will become comfortable with the temporary "growing pains" seen by Accretive Health that has dented the share price. "We believe focus will shift back to the key driver of growth."
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs